GeoPolitics Pulse

The Heartbeat of World events

AstraZeneca’s Enhertu, Akeso’s bispecifics win reimbursement in China – Fierce Pharma

by ·

AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med …Read More

Related posts:

  1. Eversana brings pharma commercialization services to Germany – Fierce Pharma
  2. FDA cracks down on China’s Hengrui in scathing manufacturing write-up – Fierce Pharma
  3. BeiGene, ex-AstraZeneca exec faces investigation in China: reports – Fierce Pharma
  4. AstraZeneca stock tanks over fears of expanding China fraud probe – Fierce Pharma
  5. SK pharmteco will build $260M peptide production plant in Korea – Fierce Pharma